These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9699714)

  • 21. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE; Zhang J; Whitton JL
    Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells.
    Chattergoon MA; Robinson TM; Boyer JD; Weiner DB
    J Immunol; 1998 Jun; 160(12):5707-18. PubMed ID: 9637479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CpG motifs of DNA vaccines induce the expression of chemokines and MHC class II molecules on myocytes.
    Stan AC; Casares S; Brumeanu TD; Klinman DM; Bona CA
    Eur J Immunol; 2001 Jan; 31(1):301-10. PubMed ID: 11265647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene-gun biolistic immunization encoding glutamic acid decarboxylase: a model for studying Langerhans cell abnormalities and mimicry in the nonobese diabetic mouse.
    Joussemet B; Vu AT; Sai P; Bach JM
    Ann N Y Acad Sci; 2005 Jun; 1051():613-25. PubMed ID: 16127002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Directly transfected langerin+ dermal dendritic cells potentiate CD8+ T cell responses following intradermal plasmid DNA immunization.
    Elnekave M; Furmanov K; Nudel I; Arizon M; Clausen BE; Hovav AH
    J Immunol; 2010 Sep; 185(6):3463-71. PubMed ID: 20713888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential advantages of DNA immunization for influenza epidemic and pandemic planning.
    Webster RG
    Clin Infect Dis; 1999 Feb; 28(2):225-9. PubMed ID: 10064231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intradermal vaccination by DNA tattooing.
    van den Berg JH; Oosterhuis K; Schumacher TN; Haanen JB; Bins AD
    Methods Mol Biol; 2014; 1143():131-40. PubMed ID: 24715286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization by application of DNA vaccine onto a skin area wherein the hair follicles have been induced into anagen-onset stage.
    Shaker DS; Sloat BR; Le UM; Löhr CV; Yanasarn N; Fischer KA; Cui Z
    Mol Ther; 2007 Nov; 15(11):2037-43. PubMed ID: 17700542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM; Ryan AA; Triccas JA; Britton WJ
    Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine-facilitated priming of CD8+ T cell responses by DNA vaccination.
    Kwissa M; Kröger A; Hauser H; Reimann J; Schirmbeck R
    J Mol Med (Berl); 2003 Feb; 81(2):91-101. PubMed ID: 12601525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.
    Xu J; Xu W; Chen X; Zhao D; Wang Y
    Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mechanism of priming cytotoxic T cell response and strategy for enhancing DNA vaccine potency in DNA immunization].
    Deng X; Cai M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Mar; 20(1):175-9. PubMed ID: 12744193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of T cell immunity by cutaneous genetic immunization with recombinant lentivector.
    He Y; Falo LD
    Immunol Res; 2006; 36(1-3):101-17. PubMed ID: 17337771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for liposomes in genetic vaccination.
    Gregoriadis G; Bacon A; Caparros-Wanderley W; McCormack B
    Vaccine; 2002 Dec; 20 Suppl 5():B1-9. PubMed ID: 12477411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha.
    Tüting T; Wilson CC; Martin DM; Kasamon YL; Rowles J; Ma DI; Slingluff CL; Wagner SN; van der Bruggen P; Baar J; Lotze MT; Storkus WJ
    J Immunol; 1998 Feb; 160(3):1139-47. PubMed ID: 9570527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virosomes for antigen and DNA delivery.
    Daemen T; de Mare A; Bungener L; de Jonge J; Huckriede A; Wilschut J
    Adv Drug Deliv Rev; 2005 Jan; 57(3):451-63. PubMed ID: 15560951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designing immune responses with genetic immunization and immunostimulatory DNA sequences.
    Thalhamer J; Leitner W; Hammerl P; Brtko J
    Endocr Regul; 2001 Sep; 35(3):143-66. PubMed ID: 11674843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.